Vir Combination
NDC 43742-2036

View NDC Profile UNII Mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. What is NDC 43742-2036?
  4. Vir Combination Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vir Combination is a UNAPPROVED HOMEOPATHIC-approved product labeled by Deseret Biologicals, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 43742-2036 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
43742-2036
Proprietary Name:
Vir Combination
Product Type: [3]
Code Navigator:

Labeler & Regulatory Data

Labeler Name: [5]
Deseret Biologicals, Inc.
Labeler Code:
43742
Product Label ID:
d48d741e-c6b2-45bd-a102-9b793f62a53c
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.

Marketing Timeline

Start Marketing Date: [9]
09-09-2021
End Marketing Date: [10]
10-01-2026
Listing Expiration Date: [11]
10-01-2026
Exclude Flag: [12]
D

Code Structure Chart

Product Details

What is NDC 43742-2036?

The NDC code 43742-2036 is assigned by the FDA to the product Vir Combination. This pharmaceutical product is labeled by Deseret Biologicals, Inc. and is currently categorized as listed product. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 43742-2036-1. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration. For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

  • INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: NY1FF92M1E)
  • INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: R0BT251SA5) (Active Moiety)
  • INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: P8ORN3UOM6)
  • INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: THG3PU0KOK) (Active Moiety)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: B93BQX9789)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 9YRA9J0KI2) (Active Moiety)
  • INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: VEH9U90EHX)
  • INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 1G2CU2LIB5) (Active Moiety)
  • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL)
  • HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL) (Active Moiety)
  • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U)
  • HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U) (Active Moiety)
  • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR)
  • HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR) (Active Moiety)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
  • HEPATITIS B VIRUS (UNII: 77H9EM77P7)
  • HEPATITIS B VIRUS (UNII: 77H9EM77P7) (Active Moiety)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN (UNII: TM54L796SN)
  • HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN (UNII: TM54L796SN) (Active Moiety)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (Active Moiety)

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the End Marketing Date? This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".